Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.

Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.

Item
http://www.wikidata.org/entity/Q42831245
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinomaCharacterization of gene expression induced by RET with MEN2A or MEN2B mutationA Drosophila model of multiple endocrine neoplasia type 2.GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation.Identification of functionally distinct TRAF proinflammatory and phosphatidylinositol 3-kinase/mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (PI3K/MEK) transforming activities emanating from RET/PTC fusion oncoproteinUpregulation of the PI3K/Akt pathway in the tumorigenesis of canine thyroid carcinomaRET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.The phosphatidylinositol 3-kinase/akt signaling pathway in medullary thyroid cancer.How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid CancerMolecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2.Central role of RET in thyroid cancer.Thyroid Cancer: Role of RET and Beyond.Thyroid C-Cell Biology and Oncogenic Transformation.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.
P2860

Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.

Item
http://www.wikidata.org/entity/Q42831245
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Increased in vivo phosphorylat ...... e endocrine neoplasia type 2B.
@en
Increased in vivo phosphorylat ...... e endocrine neoplasia type 2B.
@nl
type
label
Increased in vivo phosphorylat ...... e endocrine neoplasia type 2B.
@en
Increased in vivo phosphorylat ...... e endocrine neoplasia type 2B.
@nl
prefLabel
Increased in vivo phosphorylat ...... e endocrine neoplasia type 2B.
@en
Increased in vivo phosphorylat ...... e endocrine neoplasia type 2B.
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P50
P577
P698
P921
P1433
P1476
Increased in vivo phosphorylat ...... le endocrine neoplasia type 2B
@en
P2093
P304
P31
P407
P433
P478
P50
P577
P698
P921